Cargando…

Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?

Detalles Bibliográficos
Autores principales: Tigyi, Gábor, Dacheux, Mélanie A., Lin, Kuan-Hung, Yue, Junming, Norman, Derek, Benyó, Zoltán, Lee, Sue Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897189/
https://www.ncbi.nlm.nih.gov/pubmed/33454844
http://dx.doi.org/10.1007/s10555-021-09955-5
_version_ 1783653644357337088
author Tigyi, Gábor
Dacheux, Mélanie A.
Lin, Kuan-Hung
Yue, Junming
Norman, Derek
Benyó, Zoltán
Lee, Sue Chin
author_facet Tigyi, Gábor
Dacheux, Mélanie A.
Lin, Kuan-Hung
Yue, Junming
Norman, Derek
Benyó, Zoltán
Lee, Sue Chin
author_sort Tigyi, Gábor
collection PubMed
description
format Online
Article
Text
id pubmed-7897189
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-78971892021-03-05 Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? Tigyi, Gábor Dacheux, Mélanie A. Lin, Kuan-Hung Yue, Junming Norman, Derek Benyó, Zoltán Lee, Sue Chin Cancer Metastasis Rev Commentary Springer US 2021-01-17 2021 /pmc/articles/PMC7897189/ /pubmed/33454844 http://dx.doi.org/10.1007/s10555-021-09955-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Commentary
Tigyi, Gábor
Dacheux, Mélanie A.
Lin, Kuan-Hung
Yue, Junming
Norman, Derek
Benyó, Zoltán
Lee, Sue Chin
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
title Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
title_full Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
title_fullStr Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
title_full_unstemmed Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
title_short Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
title_sort anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897189/
https://www.ncbi.nlm.nih.gov/pubmed/33454844
http://dx.doi.org/10.1007/s10555-021-09955-5
work_keys_str_mv AT tigyigabor anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward
AT dacheuxmelaniea anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward
AT linkuanhung anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward
AT yuejunming anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward
AT normanderek anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward
AT benyozoltan anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward
AT leesuechin anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward